Roche Launches cobas Mass Spec Solution
Roche has received CE mark approval for its cobas Mass Spec solution, marking a milestone in its global launch of mass spectrometry testing.
Roche has received CE mark approval for its cobas Mass Spec solution, marking a milestone in its global launch of mass spectrometry testing.
Researchers conducted a comprehensive study on multiple myeloma, identifying early detection methods for aggressive tumors.
Finding themselves in a vicious tug-of-war, clinical labs are struggling to keep pace with emerging designer drugs.
The EXENT solution is a mass spectrometry system designed to transform diagnosis and assessment for patients with monoclonal gammopathies.
Revvity announced a distribution agreement with SCIEX aimed at advancing mass spectrometry solutions in newborn screening products.Â
The Tox Explorer Collection consists of a comprehensive library of analytes, allowing for faster identification and targeted screening assays with 1,500 compounds confirmed in a single analysis.